London – Britain has become the first country in the West to have a COVID-19 Vaccine for public use. The UK’s Department of Health and Social Care confirmed in a statement to British news agencies that the vaccine, developed jointly by American drugmaker Pfizer and Germany’s Bioentech, would be launched next week. Pfizer was the first of three major Western pharmaceutical companies to sue the U.S. for emergency consumption authorization. And applied in both Europe.
A spokesman for the Department of Health and Social Care told the British Press Association that “the government today accepted the recommendation of the Independent Medicines and Healthcare Products Regulatory Agency (MHRA) to allow the use of Pfizer / Bionettech’s Covid-19 vaccine.” The spokesman said that following months of rigorous medical tests and a thorough analysis of the data by MHRA experts, who concluded that the vaccine meets strict standards of safety, quality and efficacy, following the authorization of emergency use.
In the row of U.S. Organized in, British front line healthcare workers, care home residents, the very elderly and people with underlying conditions that make them particularly susceptible to COVID-19 complications are expected to receive the first dose of the vaccine. For the Pfizer vaccine, like the formulas of Fxford and Moder, two doses are required, except for about a month.
UK Health Secretary Matt Hancock called it “strange news” that the British regulator had considered the first vaccine safe, and promised to start distribution by Monday. He said on the BBC breakfast show that vaccinations would “start with the oldest people and those in care homes.”
Prime Minister Boris Johnson also applauded the news, confirming in a tweet that Dose plans to roll out from next week.
“It’s the defense of vaccines that will ultimately allow us to reclaim our lives and revitalize the economy.” Said Jones.
Hancock, Britain’s top public health official, noted Rational difficulties of distribution The Pfizer vaccine, which needs to be stored at about -94 degrees Fahrenheit, but said Britain would deliver 800,000 doses next week. The UK has a total of 40 million doses of the Pfizer vaccine on the fly, enough to fully treat 200 million people.
The other two vaccines, one developed by the US-based Modern, Which also requires sub-zero storage, and is manufactured by a British pharmaceutical company AstraZeneca in conjunction with Ox Xford University, U.S. And has also applied for emergency access authorization in Europe.
Both Pfizer and Moderna said that data from large-scale human trials involving thousands of people showed that their vaccines were about 95% effective in preventing Covid-19 infections. AstraZeneca / Ox Xford found their vaccine, which works in a different way, up to 90% effective with a specific dosing method. Oxford developed vaccine is much cheaper to produce, and to distribute, as it only needs to be stored at refrigerator temperature.
“This is the first Emergency Use Author Thoracicization after a worldwide Phase 3 trial of a vaccine to help fight the epidemic,” Pfizer and Bioentech said in a joint statement on Wednesday. And is ready to deliver the vaccine dose in weeks and possibly after regulatory rights or approvals. “
Albert Borla, Pfizer’s chief executive, called the UK’s move a “historic moment in the fight against COVID-19”.
None of the three leading Western-made vaccines have been shown to have significant adverse effects in human testing. Some of the side effects associated with long-used vaccines, including injections, fatigue and headaches, have been found in trial data.
Officials in China and Russia have been administering thousands of doses of the COVID-19 vaccine developed by government-backed research institutes outside the trial for weeks. Unlike Western vaccine programs, neither Russia nor China conducted large-scale, international humanitarian tests, with data provided for independent analysis before starting non-trial vaccine programs.
Trust and “Infodemic”
Logical issues aside, epidemiologists and public health officials have warned that another major obstacle to putting a coronavirus epidemic behind humanity could be distrust of available vaccines.
The World Health Organization warned on Saturday that the “infodemic” spread on social media was threatening to leave humanity at the mercy of a new coronavirus that has killed more than 1.5 million people worldwide and nearly 271,000 in the US alone.
“Coronavirus disease is the first epidemic in history in which technology and social media are being used on a large scale to keep people safe, informed, productive and connected,” the WHO said in a statement. “At the same time, the technologies we rely on to keep connected genes connected and informed enable and expand an infodemic that continues to weaken the global response and jeopardizes epidemic control measures.”
The WHO noted that both platinum platforms and politicians and other influential individuals were “deliberately trying to spread misinformation” to sow mistrust in scientific and health institutions.
The WHO warns that “without proper trust and accurate information, diagnostic tests become useless, vaccination campaigns (or campaigns to promote effective vaccines) will not achieve their goals, and the virus thrives,” the WHO warns.
a CBS News Poll Developments undertaken in early September saw growing skepticism about the coronavirus vaccine, with most voters saying that if the vaccine was made available this year, their first thought would be that it has been rushed without adequate testing.
Only 21% of voters across the country said in the survey that they would get the vaccine as soon as possible if it became available at no cost, down from 32% in a survey conducted in late July. Most said they would think about it, but wait to see what happens before others become their own.
The epidemic has seen pharmaceutical companies and research institutes work with governments and independent regulatory agencies to narrow down the process of developing and approving vaccines in a short period of time, usually over years.
The pace has been completely unprecedented, but entities associated with experts outside of infectious disease and vaccine science have insisted that the process is being safely compressed by overlapping the steps that are usually taken sequentially, without removing any steps. Trial and certification process.
Hancock, the British government’s head of health, told UK broadcaster Pierce Morgan on Wednesday that if he could be approved even though he was not in the high-risk group, he would happily be vaccinated live next week on television to show up with Morgan. His confidence in the vaccine.
.
